Synopsis
The Accelerating Clinical Trials in the EU (ACT EU) advice pilot, which helps sponsors prepare clinical trial applications, will become a permanent initiative from January 2027. The transition to a permanent initiative will ensure continued support for sponsors seeking guidance before submitting clinical trial applications through CTIS.
Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.
Read the full story at European Medicines Agency: news ↗